IP Library Granted Patent US 8,613,507
Granted Patent B2
US 8,613,507 · App. 12/906,679 · Granted Dec 24, 2013

Curable phase change inks containing functionalized isosorbides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,613,507
App. No.
12/906,679
Granted
Dec 24, 2013
Kind
B2
Abstract

A curable phase change ink composition that includes an ink vehicle including at least one isosorbide monomer having at least one functional group. Also described is an ink printing device that includes a curable phase change ink composition for printing onto a substrate, an ink jetting device, and a curing device providing radiation that cures the curable phase change ink composition. The curable phase change ink composition of the ink printing device includes an ink vehicle including at least one isosorbide monomer having at least one functional group.

Claims (21)

1. A curable phase change ink composition, the ink composition comprising an ink vehicle comprising at least one isosorbide monomer having at least one functional group, wherein the at least one functional group is selected from the group consisting of an acrylate, a methacrylate, a fatty acid having from about 4 to about 20 carbon atoms, an epoxide and an oxetane.

2. The curable phase change ink composition of claim 1 , wherein the at least one functional group is an acrylate.

3. The curable phase change ink composition of claim 1 , wherein the at least one isosorbide monomer is functionalized with two acrylate groups.

4. The curable phase change ink composition of claim 1 , wherein the at least one isosorbide monomer is represented the formula (I)

wherein R 1 represents a hydrogen atom or the at least one functional group, R 2 represents a hydrogen atom or the at least one functional group, and R 1 and R 2 are not both hydrogen atoms.

5. The curable phase change ink composition of claim 1 , wherein the ink vehicle further comprises at least a gellant, at least a curable wax and optionally at least one photoinitiator.

6. The curable phase change ink composition of claim 5 , having a gelling temperature of from about 30° C. to about 70° C.

7. The curable phase change ink composition of claim 1 , having a jetting temperature of from about 60° C. to about 90° C.

8. The curable phase change ink composition of claim 1 , further comprising at least one colorant.

9. The curable phase change ink composition of claim 8 , wherein the at least one functional group is an acrylate.

10. The curable phase change ink composition of claim 8 , wherein the at least one isosorbide monomer is represented the formula (I)

wherein R 1 represents a hydrogen atom or the at least one functional group, R 2 represents a hydrogen atom or the at least one functional group, and R 1 and R 2 are not both hydrogen atoms.

11. The curable phase change ink composition of claim 8 , wherein the at least one isosorbide monomer comprises from about 40 weight percent to about 60 weight percent of the curable phase change ink composition, and wherein the curable phase change ink composition has a jetting temperature of from about 60° C. to about 90° C.

12. The curable phase change ink composition of claim 8 , wherein the ink vehicle further comprises at least a gellant and at least a curable wax.

13. The curable phase change ink composition of claim 12 , having a gelling temperature of from about 30° C. to about 70° C.

14. The curable phase change ink composition of claim 8 , wherein the ink vehicle further comprises a curable monomer comprising from about 0.1 weight percent to about 30 weight percent of the curable phase change ink.

15. The curable phase change ink composition of claim 8 , wherein the curable phase change ink composition is a radiation-curable phase change ink composition further comprising a photoinitiator.

16. The curable phase change ink composition of claim 8 , having a jetting temperature of from about 60° C. to about 90° C.

17. The curable phase change ink composition of claim 1 , wherein the curable phase change ink composition is a radiation-curable phase change ink composition further comprising a photoinitiator.

18. The curable phase change ink composition of claim 1 , wherein the at least one functional group is selected from the group consisting of an acrylate, a methacrylate, a fatty acid having from about 4 to about 20 carbon atoms and an epoxide.

19. A curable phase change ink composition, the ink composition comprising an ink vehicle comprising at least one isosorbide monomer having at least one functional group, wherein the at least one functional group is selected from the group consisting of an acrylate, a methacrylate, a fatty acid having from about 4 to about 20 carbon atoms, an epoxide and an oxetane, wherein the at least one isosorbide monomer comprises from about 40 weight percent to about 60 weight percent of the curable phase change ink composition, and wherein the curable phase change ink composition has a jetting temperature of from about 60° C. to about 90° C.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073842/0479 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
RELEASE OF SECURITY INTEREST IN PATENTS AT R/F 062740/0214 Recorded May 18, 2023
From: CITIBANK, N.A., AS AGENT
To: XEROX CORPORATION
Reel/Frame 063694/0122 →
SECURITY INTEREST Recorded Nov 10, 2022
From: XEROX CORPORATION
To: CITIBANK, N.A., AS AGENT
Reel/Frame 062740/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2010
From: CHOPRA, NAVEEN; SACRIPANTE, GUERINO; CHRETIEN, MICHELLE N.; KEOSHKERIAN, BARKEV
To: XEROX CORPORATION
Reel/Frame 025156/0255 →